{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:26:59Z","timestamp":1771064819478,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>The sickle cell mutation increases morbidity in those with sickle cell disease (SCD) and potentially sickle cell trait, impacting pulmonary, coagulation, renal, and other systems that are implicated in COVID-19 severity. There are no population-based registries for hemoglobinopathies, and they are not tracked in COVID-19 testing. We used COVID-19 test data from 2 states linked to newborn screening data to estimate COVID outcomes in people with SCD or trait compared with normal hemoglobin. We linked historical newborn screening data to COVID-19 tests, hospitalization, and mortality data and modeled the odds of hospitalization and mortality. Georgia\u2019s cohort aged 0 to 12 years; Michigan\u2019s, 0 to 33 years. Over 8% of those in Michigan were linked to positive COVID-19 results, and 4% in Georgia. Those with SCD showed significantly higher rates of COVID-19 hospitalization than the normal hemoglobin Black cohort, and Michigan had higher rates of mortality as well. Outcomes among those with the trait did not differ significantly from the normal hemoglobin Black group. People with SCD are at increased risk of COVID-19\u2013related hospitalization and mortality and are encouraged to be vaccinated and avoid infection. Persons with the trait were not at higher risk of COVID-related severe outcomes.<\/jats:p>","DOI":"10.1097\/mph.0000000000002671","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T08:16:34Z","timestamp":1682064994000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-7657","authenticated-orcid":false,"given":"Susan T.","family":"Paulukonis","sequence":"first","affiliation":[{"name":"Tracking California at Public Health Institute, Oakland, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Snyder","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center, Georgia State University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Smeltzer","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit N.","family":"Sutaria","sequence":"additional","affiliation":[{"name":"Division of Health Protection, Georgia Department of Public Health, Maternal and Child Health Epidemiology, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Hurden","sequence":"additional","affiliation":[{"name":"Michigan Department of Health & Human Services, Detroit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista","family":"Latta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swathi","family":"Chennuri","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott","family":"Vichinsky","sequence":"additional","affiliation":[{"name":"University of California San Francisco Benioff Children\u2019s Hospital Oakland, Oakland, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research Center"},{"name":"Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"1076029620943671","DOI":"10.1177\/1076029620943671","article-title":"Coagulation status and venous thromboembolism risk in African Americans: A potential risk factor in COVID-19","volume":"26","author":"Frydman","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/bloodadvances.2021004288","article-title":"Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease","volume":"5","author":"Mucalo","year":"2021","journal-title":"Blood Adv"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"102627","DOI":"10.1016\/j.bcmd.2021.102627","article-title":"Prognostic factors associated with COVID-19 related severity in sickle cell disease","volume":"92","author":"Yurtsever","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/00333549211063518","article-title":"COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States","volume":"137","author":"Payne","year":"2022","journal-title":"Public Health Rep"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"757510","DOI":"10.3389\/fmed.2021.757510","article-title":"COVID-19 and hemoglobinopathies: A systematic review of clinical presentations, investigations, and outcomes","volume":"8","author":"Lee","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/bloodadvances.2020003741","article-title":"COVID-19 in individuals with sickle cell disease\/trait compared with other Black individuals COVID-19 in individuals with sickle cell disease\/trait compared with other Black individuals","volume":"5","author":"Singh","year":"2021","journal-title":"Blood Adv"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"100911","DOI":"10.1016\/j.blre.2021.100911","article-title":"Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature","volume":"53","author":"Hoogenboom","year":"2021","journal-title":"Blood Rev"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3324\/haematol.2021.279222","article-title":"Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York","volume":"106","author":"Hoogenboom","year":"2021","journal-title":"Haematologica"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10021","article-title":"Coagulation changes in individuals with sickle cell trait","volume":"69","author":"Westerman","year":"2002","journal-title":"Am J Hematol"},{"key":"R10-20250804","first-page":"704","article-title":"Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait","volume":"98","author":"Treadwell","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mgg3.327","article-title":"Sickle cell trait knowledge and health literacy in caregivers who receive in-person sickle cell trait education","volume":"5","author":"Creary","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2010-05-282194","article-title":"Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease","volume":"116","author":"Strouse","year":"2010","journal-title":"Blood"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pbc.22656","article-title":"Novel influenza A (H1N1) viral infection in pediatric patients with sickle-cell disease Novel influenza A (H1N1) viral infection in pediatric patients with sickle-cell disease","volume":"56","author":"Jacobs","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1177\/15353702211028560","article-title":"Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)","volume":"246","author":"Kuypers","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/bloodadvances.2020003456","article-title":"Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection","volume":"5","author":"Minniti","year":"2021","journal-title":"Blood Adv"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201105-0783OC","article-title":"Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease","volume":"184","author":"Mekontso Dessap","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12959-018-0179-z","article-title":"Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Noubiap","year":"2018","journal-title":"Thromb J"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000513198","article-title":"Hyperinflammation and Immune Response Generation in COVID-19","volume":"27","author":"Mishra","year":"2020","journal-title":"Neuroimmunomodulation"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e06033","DOI":"10.1016\/j.heliyon.2021.e06033","article-title":"Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation","volume":"7","author":"Lind","year":"2021","journal-title":"Heliyon"},{"key":"R20-20250804","first-page":"508","article-title":"Renal failure and other unusual manifestations in sickle-cell trait","volume":"63","author":"Tellem","year":"1957","journal-title":"AMA Arch Pathol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archinte.1974.00320160154014","article-title":"Renal manifestations of sickle cell disease","volume":"133","author":"Buckalew","year":"1974","journal-title":"Arch Intern Med"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"H908","DOI":"10.1152\/ajpheart.00298.2010","article-title":"Effects of hydration and dehydration on blood rheology in sickle cell trait carriers during exercise","volume":"299","author":"Tripette","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/bjh.13363","article-title":"Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory","volume":"170","author":"Key","year":"2015","journal-title":"Br J Haematol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"e0241953","DOI":"10.1371\/journal.pone.0241953","article-title":"Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients","volume":"15","author":"Yang","year":"2020","journal-title":"PLoS ONE"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1136\/bmj.290.6483.1707","article-title":"Rhabdomyolysis and acute renal failure in sickle cell anaemia","volume":"290","author":"Devereux","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.368.6490.455","article-title":"The mystery of the pandemic\u2019s \u2018happy hypoxia\u2019","volume":"368","author":"Couzin-Frankel","year":"2020","journal-title":"Science"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/archinte.1963.03860020120016","article-title":"Hyposthenuria in sickle cell states","volume":"112","author":"Cochran","year":"1963","journal-title":"Arch Intern Med"},{"key":"R29-20250804","first-page":"358","article-title":"The sickle cell trait in relation to the training and assignment of duties in the armed forces: III. Hyposthenuria, hematuria, sudden death, rhabdomyolysis, and acute tubular necrosis","volume":"55","author":"Diggs","year":"1984","journal-title":"Aviat Space Environ Med"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-0031-1273087","article-title":"Thrombosis and sickle cell disease","volume":"37","author":"De Franceschi","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-6306","article-title":"Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths : A systematic review","volume":"174","author":"Mackey","year":"2021","journal-title":"Ann Intern Med"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/pmrj.12668","article-title":"Public health adherence and information-seeking for people with chronic conditions during the early phase of the COVID-19 pandemic","volume":"13","author":"Roberts","year":"2021","journal-title":"PM R"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1182\/bloodadvances.2021004977","article-title":"Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection","volume":"5","author":"Merz","year":"2021","journal-title":"Blood Adv"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2022.2141","article-title":"Association of kidney comorbidities and acute kidney failure with unfavorable outcomes after COVID-19 in individuals with the sickle cell trait","volume":"182","author":"Verma","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/bloodadvances.2022007622","article-title":"Hematologist encounters among medicaid patients who have sickle cell disease","volume":"6","author":"Horiuchi","year":"2022","journal-title":"Blood Adv"},{"key":"R38-20250804","first-page":"e21026","article-title":"COVID-19 vaccine perception and hesitancy among patients with sickle cell disease in the Western Region of Saudi Arabia","volume":"14","author":"Jan","year":"2022","journal-title":"Cureus"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:08:47Z","timestamp":1754338127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002671","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"2022-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}